Back to search
FDAFDA · Food and drugs·Recall number Z-1480-2022

Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy (CRT-D)

Published August 3, 2022 · Recall initiated: November 5, 2020

Summary

FDA records medical device Class II recall Z-1480-2022, published August 3, 2022 and initiated November 5, 2020. Recalling firm: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF); Status: Ongoing; Reported quantity: 3 units; Lot: GTIN 00763000178178, Serial Numbers: RTK601865S, RTK601825S, RTK601828S. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Manufacturing error that may have resulted in a cathode component being out of specification. All devices met final functional testing requirements.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Distributor
US Nationwide distribution in the states of Indiana and CA.
Lot
GTIN 00763000178178, Serial Numbers: RTK601865S, RTK601825S, RTK601828S
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy (CRT-D) recalled?

Yes. FDA published recall Z-1480-2022 on August 3, 2022. Reported hazard: Manufacturing error that may have resulted in a cathode component being out of specification. All devices met final functional testing requirements.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone